Classification of the tumor immune microenvironment and associations with outcomes in patients with metastatic melanoma treated with immunotherapies — Nurudeen A. Adegoke (2023) | RDL Network
Classification of the tumor immune microenvironment and associations with outcomes in patients with metastatic melanoma treated with immunotherapies
Article 2023 en
Authors
NA
Nurudeen A. Adegoke
TG
Tuba N. Gide
YM
Yizhe Mao
Abstract
1 min read
Our study provides an automatic TME classification method that may predict the clinical efficacy of immunotherapy for patients with metastatic melanoma.
Tuba N. Gide, Elizabeth C. Paver, Zarwa Yaseen, Nigel Maher, Nurudeen A. Adegoke, Alexander M. Menzies, Inês Pires da Silva, James S. Wilmott, Georgina V. Long, Richard A Scolyer
Jordan W. Conway, Robert V. Rawson, Serigne Lo, Tasnia Ahmed, Ismael A. Vergara, Tuba N. Gide, Grace H. Attrill, Matteo S. Carlino, Robyn P.M. Saw, John F. Thompson, Andrew J. Spillane, Kerwin F. Shannon, Brindha Shivalingam, Alexander M. Menzies, James S. Wilmott, Georgina V. Long, Richard A Scolyer, Inês Pires da Silva
Grant M. Fischer, Fernando C. L. Carapeto, Aron Y. Joon, Lauren E. Haydu, Huiqin Chen, Fuchenchu Wang, John S. Van Arnam, Jennifer L. McQuade, Khalida Wani, John M. Kirkwood, John F. Thompson, Michael T. Tetzlaff, Alexander J. Lazar, Hussein A. Tawbi, Jeffrey E. Gershenwald, Richard A Scolyer, Georgina V. Long, Michael A. Davies
Tuba N. Gide, Camelia Quek, Jason Madore, Alexander M. Menzies, Rebecca Dent, Matteo S. Carlino, Alex Guminski, Robyn P.M. Saw, John F. Thompson, James S. Wilmott, Richard A Scolyer, Georgina V. Long
Discussion(0)
No comments yet. Be the first to comment.